dabigatran has been researched along with glucuronyl glucosamine glycan sulfate in 2 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (glucuronyl glucosamine glycan sulfate) | Trials (glucuronyl glucosamine glycan sulfate) | Recent Studies (post-2010) (glucuronyl glucosamine glycan sulfate) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 284 | 81 | 133 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreozzi, GM; Bignamini, AA; Kuca, P; Tomkowski, W | 1 |
| Imberti, D; Mastroiacovo, D; Pomero, F | 1 |
1 review(s) available for dabigatran and glucuronyl glucosamine glycan sulfate
| Article | Year |
|---|---|
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Dabigatran; Glycosaminoglycans; Hemorrhage; Humans; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk Factors; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Vitamin K | 2020 |
1 other study(ies) available for dabigatran and glucuronyl glucosamine glycan sulfate
| Article | Year |
|---|---|
Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Glycosaminoglycans; Hemorrhage; Humans; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Venous Thromboembolism | 2017 |